Cholinergic Receptor Nicotinic Alpha Subunit 4

Cholinergic Receptor Nicotinic Alpha Subunit 4

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Cholinergic Receptor Nicotinic Alpha Subunit 4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CHRNA4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cholinergic Receptor Nicotinic Alpha Subunit 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>20q13.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1137</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>118504</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00001202073</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P43681</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Cholinergic Receptor Nicotinic Alpha Subunit 4 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Cholinergic Receptor Nicotinic Alpha Subunit 4

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Cholinergic Receptor Nicotinic Alpha Subunit 4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CHRNA4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cholinergic Receptor Nicotinic Alpha Subunit 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>20q13.31</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1137</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>118504</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00001202073</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P43681</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Cholinergic Receptor Nicotinic Alpha Subunit 4 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

CHRNA4 encodes the alpha 4 subunit of the nicotinic [acetylcholine](/entities/acetylcholine) receptor, a ligand-gated ion channel that mediates fast synaptic transmission. The α4β2 nicotinic receptor is the most abundant nicotinic receptor in the brain and is critical for cognitive function, attention, and reward processing. CHRNA4 mutations cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). The receptor is a therapeutic target for smoking cessation and cognitive enhancement. [@beta]

Gene Information

Normal Function

Nicotinic α4β2 receptor function:

• Ion channel: Permits Na+ and Ca2+ influx
• Cognitive enhancement: Attention, working memory
• Reward processing: Mesolimbic dopamine modulation
• Wide distribution: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), thalamus

Disease Associations

• ADNFLE: CHRNA4 mutations cause nocturnal seizures
• Smoking behavior: Nicotine addiction pathways
• Cognitive decline: [Alzheimer's disease](/diseases/alzheimers-disease) vulnerability

Therapeutic Implications

• Smoking cessation: Varenicline targets α4β2
• Cognitive enhancement: Nicotinic agonists
• ADNFLE: Antiepileptic strategies

See Also

• [Nicotinic Acetylcholine Receptors](/entities/nicotinic-receptor)
• [Acetylcholine Signaling](/mechanisms/acetylcholine-pathway)
• [Epilepsy](/diseases/epilepsy)

External Links

• [NCBI Gene: CHRNA4](https://www.ncbi.nlm.nih.gov/gene/1137)
• [UniProt: CHRNA4](https://www.uniprot.org/uniprot/P43681)

Background

The study of Cholinergic Receptor Nicotinic Alpha Subunit 4 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Protein Structure

The nicotinic acetylcholine receptor (nAChR) is a pentameric ligand-gated ion channel:

[@alpha]: Alpha subunits: Binding sites for acetylcholine
[@beta]: Beta subunits: Modulatory subunits
[@stoichiometry]: Stoichiometry: Typically (α4)₂(β2)₃ in brain
[@transmembrane]: transmembrane domains: Five subunits arrange around central pore

Receptor Subtypes

• α4β2: Most abundant in brain, high affinity for nicotine
• α4β4: Higher sensitivity, found in peripheral nervous system
• α4-containing: Include α4β2, α4β4, α4δ, α4γ

Expression Pattern

CHRNA4 shows region-specific expression:

• Hippocampus: High expression in CA1-CA3 regions
• Cortex: Layer 5 pyramidal neurons
• Thalamus: Relay neurons
• Basal ganglia: Striatal interneurons
• Substantia nigra: Pars compacta dopaminergic neurons

Molecular Mechanisms

Channel Gating

• Calcium signaling: Ca²⁺ influx activates calmodulin

Role in Neurodegeneration

Alzheimer's Disease

• ↓ α4β2 receptor density in AD cortex
• Correlates with cognitive decline
• Nicotinic agonists show cognitive benefit
• Connection to cholinergic hypothesis

Parkinson's Disease

• Loss of α4β2 in substantia nigra
• Nicotine may provide neuroprotection
• Smoking paradox (protective but harmful)

Cognitive Function

• Attention and working memory
• Spatial memory formation
• Executive function

Animal Models

• CHRNA4 knockout mice: Show cognitive deficits
• Transgenic models: Overexpression studies
• Humanized mice: Express human CHRNA4

Clinical Significance

ADNFLE (Autosomal Dominant Nocturnal Frontal Lobe Epilepsy)

• Onset: Childhood to adolescence
• Seizure type: Nocturnal focal seizures
• Mutation types: Point mutations in M1-M4 domains

Therapeutic Targets

• Varenicline (Chantix): Partial agonist at α4β2
• Cytisine: Agonist used in smoking cessation
• ABT-594: Experimental cognitive enhancer

References